Avanos Medical, Inc.
AVNS
$12.15
-$0.56-4.41%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 101.66% | -9,339.53% | 138.89% | 300.00% | -108.57% |
| Total Depreciation and Amortization | -13.51% | -5.13% | 3.54% | -0.88% | -0.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.97% | 11,993.94% | -48.44% | 82.86% | 202.94% |
| Change in Net Operating Assets | -88.00% | 1,116.22% | -55.42% | 137.73% | -272.88% |
| Cash from Operations | -55.61% | 151.74% | -17.27% | 447.50% | -162.99% |
| Capital Expenditure | -39.58% | -60.00% | 49.15% | -43.90% | 30.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | -97.64% |
| Other Investing Activities | 14.29% | 68.89% | -- | -- | -- |
| Cash from Investing | -19.74% | 36.67% | -103.39% | -195.00% | -102.47% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 0.00% | -106.82% | -780.00% | 87.07% | 87.99% |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | -2,100.00% | 0.00% | 97.14% | 61.54% | -42.19% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | 100.00% | 95.73% |
| Cash from Financing | -6.20% | -71.25% | -220.00% | -614.29% | 99.39% |
| Foreign Exchange rate Adjustments | 142.86% | -333.33% | 460.00% | 58.33% | -175.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.22% | 684.38% | -119.51% | 237.82% | 38.66% |